Pakistan’s first major heart study reveals widespread cardiac risks in healthy adults


  • WEB DESK
  • November 21, 2026
A member of the medical staff stands next to a monitor at the intensive care unit (ICU) of the Sotiria hospital in Athens, Greece, March 18, 2021. — REUTERS

Preliminary results of Pakistan’s first comprehensive study of 2,000 healthy adults with no symptoms of disease show that 78 per cent are obese, 33 per cent hypertensive and 22 per cent diabetic, with another 23 per cent prediabetic, leading cardiologists said on Saturday.

Dr Bashir Hanif, the study’s principal investigator, said obesity, defined by an Asian BMI cut-off of 25, was found in 81 per cent of women and 74 per cent of men. A further 32 per cent reported a family history of premature coronary heart disease, he said, while 68 per cent had low levels of “good” HDL cholesterol.

He was presenting the baseline findings at the primary prevention session of the 55th CardioCon at the Serena Hotel on Saturday.

The Pakistan Study of Premature Coronary Atherosclerosis in Young Adults (PAK-SEHAT) is a prospective cohort study conducted jointly by the Fatima Hanif Foundation and Getz Pharma, which took the initiative through an unrestricted research grant.

Described as the first of its kind in the country, it has been dubbed a “mini Framingham” of Pakistan, after the landmark US heart study.

“The participants, men aged 35 to 60 and women aged 35 to 65, were recruited from all four provinces and Islamabad through eight centres. None has symptomatic cardiovascular disease. Their mean age was 39”, Dr Hanif said, adding that baseline assessment includes blood tests, carotid ultrasound and coronary CT angiography, with follow-up for five years.

Dr Bashir Hanif said risk factors did not occur in isolation, as hypertension, dyslipidaemia, obesity and diabetes coexisted in the same individuals, and a greater accumulation of them corresponded to substantially more silent atherosclerosis.

“Calcium was found in the coronary arteries of 26 per cent of participants”, he said, and conventional clinical risk assessment could underestimate the disease actually present.

Dr Khurram Nasir, co-principal investigator and chief of the Division of Cardiovascular Prevention and Wellness at Houston Methodist, said PAK-SEHAT would be a “gold mine” of data for Pakistan.

South Asians, especially Pakistanis, remained largely “invisible” in global research, he said, so little is known about the causes, early onset and risk factors of heart disease in them.

Dr Nasir, who is also editor-in-chief of the American Journal of Preventive Cardiology, said the results suggested that being a man aged 35 or above was itself a risk factor for Pakistanis, possibly owing to sedentary lifestyles, genetics and environmental factors. Details would emerge once the study was finalised.

He said heart disease appeared to begin 10 to 15 years earlier in Pakistanis than in other populations. Yet nobody knew why younger people and men suffered early heart attacks and deaths, because the question had never been investigated.

PAK-SEHAT, he said, would show why disease started early and how to prevent it.

He paid tribute to Dr Hanif and Getz Pharma for making the landmark study possible.

Kashif Amin, Head of Public Health at Getz Pharma, said cardiovascular disease claims lives silently in Pakistan, while guidelines and risk-scoring models have relied on Western data, so prevention must begin with the country’s own data.

He said Getz Pharma’s vision goes beyond medicines to shifting from late-stage treatment to primary prevention, with PAK-SEHAT, a multicentric prospective study, at its heart.

Uncovering subclinical atherosclerosis and mapping how hypertension, diabetes, dyslipidaemia and lifestyle factors interact, he called it a national blueprint for protecting Pakistan’s youth, workforce and families, adding that Getz Pharma will keep connecting clinicians, investigators and the population.

You May Also Like

WhatsApp